|Description||Activator of pyruvate kinase isoenzyme M2 (PKM2), an enzyme involved in glycolysis. Since all tumor cells exclusively express the embryonic M2 isoform of PK, it is hypothesized that PKM2 is a potential target for cancer therapy. Modulation of PKM2 might also be effective in the treatment of obesity, diabetes, autoimmune conditions, and antiproliferation-dependent diseases.|
|B0084-463157||100 mg||$599||In stock|
|Synonyms||PKR-IN-1; PKM2 activator 1020; PKM2 activator; Mitapivat.|
NCT-501 is a potent and selective inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1) with IC50 of 40 nM.
Laquinimod, also known as, is an experimental immunomodulator developed by Active Biotech and Teva. It is being investigated as an oral treatment for multiple ...
(±)-Epibatidine is a potent nicotinic agonist (Ki = 0.02 and 233 nM for α4β2 and α7 nicotinic receptors, respectively).
JZP-430, a thiadiazol derivative, has been found to be an ABHD6 inhibitor that could probably be effective in obesity and type II diabetes therapy. IC50: 44 nM.
D, L-3-Indolylglycine, similar to Tryptophan, is an unnatural amino acid.
A potent inhibitor of protein tyrosine kinase (PTK)
NADPH tetrasodium salt
NADPH tetrasodium salt is an ubiquitous coenzyme that acts as an electron donor in various biological reactions.<br/>Nutritional supplement in health care produ...
Isoastragaloside I is a natural compound from the medicinal herb Radix Astragali. It possesses the activity of elevating adiponectin production. It selectively ...